Biology Reference
In-Depth Information
[36] Ouyang W, Ranganath SH, Weindel K, et al. Inhibition of Th1 development mediated by
GATA-3 through an IL-4-independent mechanism. Immunity 1998;9(5):745-55.
[37] Zhu J, Min B, Hu-Li J, et al. Conditional deletion of Gata3 shows its essential function in
T(H)1-T(H)2 responses. Nat Immunol 2004;5(11):1157-65.
[38] Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to
inhibit cytokine production by Th1 cells. J Immunol 1991;146(10):3444-51.
[39] Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and Il4 locus
accessibility. Annu Rev Immunol 2006;24:607-56.
[40] Mohrs M, Blankespoor CM, Wang ZE, et al. Deletion of a coordinate regulator of type 2
cytokine expression in mice. Nat Immunol 2001;2(9):842-7.
[41] Yamashita M, Ukai-Tadenuma M, Kimura M, et al. Identification of a conserved GATA3
response element upstream proximal from the interleukin-13 gene locus. J Biol Chem
2002;277(44):42399-408.
[42] Lee HJ, O'Garra A, Arai K, Arai N. Characterization of cis-regulatory elements and
nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-
binding protein. J Immunol 1998;160(5):2343-52.
[43] Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4
(IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro genera-
tion of IL-4-producing cells. J Exp Med 1990;172(3):921-9.
[44] Guo L, Wei G, Zhu J, et al. IL-1 family members and STAT activators induce cytokine
production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 2009;106(32):13463-8.
[45] Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat
Rev Immunol 2010;10(4):225-35.
[46] Yang XO, Angkasekwinai P, Zhu J, et al. Requirement for the basic helix-loop-
helix transcription factor Dec2 in initial TH2 lineage commitment. Nat Immunol
2009;10(12):1260-6.
[47] Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by
downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immu-
nity 2003;18(3):415-28.
[48] Yagi R, Junttila IS, Wei G, et al. The transcription factor GATA3 actively represses RUNX3
protein-regulated production of interferon-gamma. Immunity 2010;32(4):507-17.
[49] Kohu K, Ohmori H, Wong WF, et al. The Runx3 transcription factor augments Th1 and
down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J Immu-
nol 2009;183(12):7817-24.
[50] Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse
CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity
1995;2(3):271-9.
[51] Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8
effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type
2 versus type 1 cytokine profiles. J Exp Med 1994;180(5):1715-28.
[52] Carter LL, Dutton RW. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 ef-
fector populations. J Immunol 1995;155(3):1028-31.
[53] Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the
most reliable marker for the detection of circulating human type 2 Th and type 2 T
cytotoxic cells in health and disease. Eur J Immunol 2000;30(10):2972-9.
[54] Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW. Tc1 and Tc2 effector cell thera-
py elicit long-term tumor immunity by contrasting mechanisms that result in comple-
mentary endogenous type 1 antitumor responses. J Immunol 2004;172(3):1380-90.
[55] Amarnath S, Flomerfelt FA, Costanzo CM, et al. Rapamycin generates anti-apoptotic
human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy
2010;6(4):523-41.
[56] Via CS, Finkelman FD. Critical role of interleukin-2 in the development of acute graft-
versus-host disease. Int Immunol 1993;5(6):565-72.
[57] Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Blockade of CD40 ligand-CD40 in-
teraction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell
expansion and function after bone marrow transplantation. J Immunol 1997;158(1):29-
39.
[58] Via CS, Rus V, Gately MK, Finkelman FD. IL-12 stimulates the development of acute
graft-versus-host disease in mice that normally would develop chronic, autoimmune
graft-versus-host disease. J Immunol 1994;153(9):4040-7.
[59] Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in
acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J
Exp Med 1996;183(6):2645-56.
[60] Kataoka Y, Iwasaki T, Kuroiwa T, et al. The role of donor T cells for target organ injuries
in acute and chronic graft-versus-host disease. Immunology 2001;103(3):310-8.
242
Search WWH ::




Custom Search